Aligned Genetics Inc (238120) — Cash Flow Quality Index
Aligned Genetics Inc (238120) has a Cash Flow Quality Index of -2.19x as of September 2025. Operating cash flow of ₩-2.04 Billion is below net income of ₩933.05 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Aligned Genetics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Aligned Genetics Inc Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for Aligned Genetics Inc across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 238120 cash flow conversion.
Annual Cash Flow Quality Index for Aligned Genetics Inc (2019–2024)
Year-by-year earnings quality comparison for Aligned Genetics Inc.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.74x | ₩3.07 Billion | ₩4.13 Billion | ▼ -15.6% |
| 2023 | 0.88x | ₩2.85 Billion | ₩3.24 Billion | ▼ -7.6% |
| 2022 | 0.95x | ₩2.22 Billion | ₩2.33 Billion | ▲ +3782.9% |
| 2021 | 0.02x | ₩135.97 Million | ₩5.54 Billion | ▼ -67.8% |
| 2020 | 0.08x | ₩35.67 Million | ₩468.23 Million | ▼ -98.7% |
| 2019 | 5.65x | ₩659.29 Million | ₩116.74 Million | — |